Non-insulin-dependent diabetes. Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Intervention 1: Intervention group: In addition to routine treatment of diabetes to control blood sugar under approved therapy protocols, patients will receive three500 mg capsules of cinnamon daily b
Treatment - Drugs
Placebo
Intervention group: In addition to routine treatment of diabetes to control blood sugar under approved therapy protocols, patients will receive three500 mg capsules of cinnamon daily before breakfast,
Control group: In addition to routine treatment of diabetes to control blood sugar under approved therapy protocols, samples will receive daily three vitamin C capsules as placebo that their shape, si
Sponsors
Vice chancellor for research, Birjand University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: type II non-insulin dependent diabetes, blood levels of hemoglobin A1C between 6.5 and 7.5, desire to participate in the study. Exclusion criteria: not regular referring to diabetes control center, hemolytic anemia and thalassemia diseases, recent infusion of blood, uremia, allergy to cinnamon, kidney, liver and parathyroid diseases and intestinal problems, pregnancy, lactation, drug intolerance, signs of allergy to cinnamon, taking insulin, unexpected events and death
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting glucose levels. Timepoint: Before intervention and 90 days after taking medication. Method of measurement: Blood sampling and determination of fasting glucose levels by enzymatic method.;Hemoglobin A1C. Timepoint: Before intervention and 90 days after taking medication. Method of measurement: Blood sampling and determination of the glycosylated hemoglobin by HPLC method. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAzadeh zahedifar
Birjand University of Medical Sciences
Outcome results
None listed